Pharmacological concentrations of ascorbate radiosensitize glioblastoma multiforme primary cells by increasing oxidative DNA damage and inhibiting G2/M arrest.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Free Radical Biology & Medicine

• Publication date

  2012-04-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.freeradbiomed.2012.01.021PMID 22342518
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ascorbate induces autophagy in pancreatic cancer.

  2013cited by this paper
• Side Population is Not Necessary or Sufficient for a Cancer Stem Cell Phenotype in Glioblastoma Multiforme

  2011cited by this paper
• Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer.

  2011cited by this paper
• Enhancement of radiosensitivity in human glioblastoma cells by the DNA N-mustard alkylating agent BO-1051 through augmented and sustained DNA damage response

  2011cited by this paper
• Ascorbic acid enhances radiation-induced apoptosis in an HL60 human leukemia cell line.

  2011cited by this paper
• Concomitant temozolomide and radiotherapy versus radiotherapy alone for treatment of newly diagnosed glioblastoma multiforme.

  2011cited by this paper
• Sorafenib enhances pemetrexed cytotoxicity through an autophagy-dependent mechanism in cancer cells

  2011cited by this paper
• Clinical trials of antioxidants as cancer prevention agents: past, present, and future.

  2011cited by this paper
• Anti-cancer effect of pharmacologic ascorbate and its interaction with supplementary parenteral glutathione in preclinical cancer models.

  2011influential reference
• BMI1 Confers Radioresistance to Normal and Cancerous Neural Stem Cells through Recruitment of the DNA Damage Response Machinery

  2010cited by this paper
• DNA-PKcs plays a dominant role in the regulation of H2AX phosphorylation in response to DNA damage and cell cycle progression

  2010cited by this paper
• Vitamin C: Intravenous Use by Complementary and Alternative Medicine Practitioners and Adverse Effects

  2010cited by this paper
• Ascorbate induces autophagy in pancreatic cancer

  2010cited by this paper
• Dual Role of 3-Methyladenine in Modulation of Autophagy via Different Temporal Patterns of Inhibition on Class I and III Phosphoinositide 3-Kinase*

  2010cited by this paper
• Mechanisms of Ascorbate-Induced Cytotoxicity in Pancreatic Cancer

  2010influential reference
• Low ascorbate levels are associated with increased hypoxia-inducible factor-1 activity and an aggressive tumor phenotype in endometrial cancer.

  2010cited by this paper
• Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

  2009cited by this paper
• Why are tumour blood vessels abnormal and why is it important to know?

  2009cited by this paper
• CD133+ Glioblastoma Stem-like Cells are Radiosensitive with a Defective DNA Damage Response Compared with Established Cell Lines

  2009cited by this paper
• Cytometric analysis of DNA damage: phosphorylation of histone H2AX as a marker of DNA double-strand breaks (DSBs).

  2009cited by this paper
• What drives intense apoptosis resistance and propensity for necrosis in glioblastoma? A role for Bcl2L12 as a multifunctional cell death regulator

  2008cited by this paper
• Ascorbate interacts with reduced glutathione to scavenge phenoxyl radicals in HL60 cells.

  2008influential reference
• Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice

  2008influential reference
• Comparison of nonhomologous end joining and homologous recombination in human cells.

  2008cited by this paper
• Phase I clinical trial of i.v. ascorbic acid in advanced malignancy.

  2008cited by this paper
• Ascorbate deficiency results in impaired neutrophil apoptosis and clearance and is associated with up-regulation of hypoxia-inducible factor 1alpha.

  2007cited by this paper
• Cell biology: Autophagy and cancer

  2007cited by this paper
• Ascorbate deficiency results in impaired neutrophil apoptosis and clearance and is associated with up‐regulation of hypoxia‐inducible factor 1α

  2007cited by this paper
• Investigation of the role of extracellular H2O2 and transition metal ions in the genotoxic action of ascorbic acid in cell culture models.

  2007cited by this paper
• Tumor suppressor 101F6 and ascorbate synergistically and selectively inhibit non-small cell lung cancer growth by caspase-independent apoptosis and autophagy.

  2007cited by this paper
• Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo

  2007influential reference
• Modulation of hypoxia-inducible factor-1 alpha in cultured primary cells by intracellular ascorbate.

  2007cited by this paper
• Vitamins C and K3 sensitize human urothelial tumors to gemcitabine.

  2006cited by this paper
• Bcl-2 inhibition of autophagy: a new route to cancer?

  2006cited by this paper
• H2O2-mediated Cytotoxicity of Pharmacologic Ascorbate Concentrations to Neuroblastoma Cells: Potential Role of Lactate and Ferritin

  2006cited by this paper
• The effect of intracellular ascorbate on the susceptibility of HL60 and Jurkat cells to chemotherapy agents

  2006cited by this paper
• Intravenously administered vitamin C as cancer therapy: three cases

  2006cited by this paper
• Investigation of factors responsible for cell line cytoplasmic expression differences

  2005cited by this paper
• A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients.

  2005cited by this paper
• Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues.

  2005influential reference
• Vitamin C Pharmacokinetics: Implications for Oral and Intravenous Use

  2004cited by this paper
• L‐ascorbic acid represses constitutive activation of NF‐κB and COX‐2 expression in human acute myeloid leukemia, HL‐60

  2004cited by this paper
• Role of cell cycle in mediating sensitivity to radiotherapy.

  2004cited by this paper
• Manganese Superoxide Dismutase-Mediated Gene Expression in Radiation-Induced Adaptive Responses

  2003cited by this paper
• Molecular response of human glioblastoma multiforme cells to ionizing radiation: cell cycle arrest, modulation of the expression of cyclin-dependent kinase inhibitors, and autophagy.

  2003cited by this paper
• Effector Genes Altered in MCF-7 Human Breast Cancer Cells after Exposure to Fractionated Ionizing Radiation

  2001cited by this paper
• Ascorbic acid (vitamin C) improves the antineoplastic activity of doxorubicin, cisplatin, and paclitaxel in human breast carcinoma cells in vitro.

  1996cited by this paper
• Potentiation of growth inhibition due to vincristine by ascorbic acid in a resistant human non-small cell lung cancer cell line.

  1995cited by this paper
• Ascorbic acid enhances the effects of 6-hydroxydopamine and H2O2 on iron-dependent DNA strand breaks and related processes in the neuroblastoma cell line SK-N-SH.

  1991cited by this paper
• Antioxygenic Enzyme Activities in Differentiating Human Neuroblastoma Cells a

  1988cited by this paper
• High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison.

  1985cited by this paper
• 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes.

  1982cited by this paper
• Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial.

  1979cited by this paper
• Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer.

  1978cited by this paper
• Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer.

  1976cited by this paper
• The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer.

  1974cited by this paper

• Pharmacological Vitamin C-induced high H2O2 generation mediates apoptotic cell death by caspase 3/7 activation in breast cancer tumor spheroids

  2025cites this paper
• The effect and related mechanisms of RAC1 GTP on radiotherapy for hepatocellular carcinoma

  2025cites this paper
• Balanced Duality: H2O2-Based Therapy in Cancer and Its Protective Effects on Non-Malignant Tissues

  2024cites this paper
• Comparative Analysis of Biological Potential of Acerola By-Product Extracts Obtained by Hydrothermal and Gas-Expanded Liquid Extraction

  2024cites this paper
• Differential H2O2 Metabolism among Glioblastoma Subtypes Confers Variable Responses to Pharmacological Ascorbate Therapy Combined with Chemoradiation

  2023cites this paper
• Hydrogen Peroxide Mediates Pharmacological Ascorbate Induced Radio-Sensitization of Pancreatic Cancer Cells by Enhancing G2-accumulation and Reducing Cyclin B1 Protein Levels

  2023cites this paper
• Bioactive compounds from Actinidia arguta fruit as a new strategy to fight glioblastoma.

  2023cites this paper
• Vitamin C Modes of Action in Calcium-Involved Signaling in the Brain

  2023cites this paper
• The Result of Vitamin C Treatment of Patients with Cancer: Conditions Influencing the Effectiveness

  2022cites this paper
• Antioxidants in brain tumors: current therapeutic significance and future prospects

  2022cites this paper
• Impact of combining vitamin C with radiation therapy in human breast cancer: does it matter?

  2022cites this paper
• Falnidamol and cisplatin combinational treatment inhibits non-small cell lung cancer (NSCLC) by targeting DUSP26-mediated signal pathways.

  2022cites this paper
• The DNA Double-Strand Break Repair in Glioma: Molecular Players and Therapeutic Strategies

  2022cites this paper
• The Multifaceted Glioblastoma: From Genomic Alterations to Metabolic Adaptations.

  2021cites this paper
• Exploring the Pivotal Neurophysiologic and Therapeutic Potentials of Vitamin C in Glioma

  2021influential citation
• Two Distinct Faces of Vitamin C: AA vs. DHA

  2021cites this paper
• Change in microRNAs Expression Profile of Glioblastoma Multiforme (GBM) Cell Lines Following Treatment By Ascorbic Acid

  2021cites this paper
• Clinical Utility of Pharmacological Ascorbate in Veterinary Oncology

  2021cites this paper
• Safety and Efficacy Assessments to Take Antioxidants in Glioblastoma Therapy: From In Vitro Experiences to Animal and Clinical Studies.

  2021cites this paper
• Parenteral high-dose ascorbate - A possible approach for the treatment of glioblastoma (Review)

  2021cites this paper
• Complementary and alternative medicine in children with diffuse intrinsic pontine glioma—A SIOPE DIPG Network and Registry study

  2021cites this paper
• The Role of 2-Oxoglutarate Dependent Dioxygenases in Gliomas and Glioblastomas: A Review of Epigenetic Reprogramming and Hypoxic Response

  2021cites this paper
• 1H-NMR based metabolic profiles delineate the anticancer effect of vitamin C and oxaliplatin on hepatocellular carcinoma cells.

  2020cites this paper
• Witamina C w terapii przeciwnowotworowej? – przegląd danych klinicznych i przedklinicznych

  2020cites this paper
• Ascorbate-induced oxidative stress mediates TRP channel activation and cytotoxicity in human etoposide-sensitive and -resistant retinoblastoma cells

  2020cites this paper
• The Radio-Sensitizing Effect of Pharmacological Concentration of Ascorbic Acid on Human Pancreatic Cancer Cells.

  2020cites this paper
• Vitamin C Promotes Apoptosis and Cell Cycle Arrest in Oral Squamous Cell Carcinoma

  2020cites this paper
• Nuclear and Cytoplasmic Functions of Vitamin C

  2020cites this paper
• effects of combined inhibition of sTaT3 and VegFr2 pathways on the radiosensitivity of non-small-cell lung cancer cells

  2019cites this paper
• Metabolic control by dehydroascorbic acid: Questions and controversies in cancer cells

  2019cites this paper
• Effects of combined inhibition of STAT3 and VEGFR2 pathways on the radiosensitivity of non-small-cell lung cancer cells

  2019cites this paper
• Calculated cell‐specific intracellular hydrogen peroxide concentration: Relevance in cancer cell susceptibility during ascorbate therapy

  2018cites this paper
• The effect of vitamin C and iron on dopamine-mediated free radical generation: implications to Parkinson's disease.

  2018cites this paper
• Ascorbic Acid, Still Controversial in Using against Cancer Resistance?

  2018cites this paper
• Pharmacological Ascorbate Suppresses Growth of Gastric Cancer Cells with GLUT1 Overexpression and Enhances the Efficacy of Oxaliplatin Through Redox Modulation

  2018cites this paper
• Potential Mechanisms of Action for Vitamin C in Cancer: Reviewing the Evidence

  2018cites this paper
• Intravenous Vitamin C for Cancer Therapy – Identifying the Current Gaps in Our Knowledge

  2018cites this paper
• Vitamin C in the critically ill - indications and controversies

  2018cites this paper
• RBBP6 increases radioresistance and serves as a therapeutic target for preoperative radiotherapy in colorectal cancer

  2018cites this paper
• The Effect of Ascorbic Acid over the Etoposide- and Temozolomide-Mediated Cytotoxicity in Glioblastoma Cell Culture: A Molecular Study.

  2018cites this paper
• Pharmacological Ascorbate as an Adjuvant for Enhancing Radiation-Chemotherapy Responses in Gastric Adenocarcinoma

  2018cites this paper
• Vitamin C preferentially kills cancer stem cells in hepatocellular carcinoma via SVCT-2

  2018cites this paper
• Ascorbic acid: still controversial when used against cancer resistance?

  2017cites this paper
• SVCT-2 determines the sensitivity to ascorbate-induced cell death in cholangiocarcinoma cell lines and patient derived xenografts.

  2017cites this paper
• Peroxiporin Expression Is an Important Factor for Cancer Cell Susceptibility to Therapeutic H2O2: Implications for Pharmacological Ascorbate Therapy

  2017cites this paper
• Additional Therapies and Innovative Technologies

  2017cites this paper
• Ascorbic acid does not reduce the anticancer effect of radiotherapy.

  2017cites this paper
• Multiple Myeloma Tumor Cells are Selectively Killed by Pharmacologically-dosed Ascorbic Acid

  2017cites this paper
• High Dose Ascorbate Causes Both Genotoxic and Metabolic Stress in Glioma Cells

  2017cites this paper
• Dietary Supplements Commonly Used by Cancer Survivors: Are There Any Benefits?

  2017cites this paper
• A Clinician's Guide to Integrative Oncology

  2017cites this paper
• Metabolic Production of H 2 O 2 in Carcinogenesis and Cancer Treatment

  2016cites this paper
• Micronutrients in Oncological Intervention

  2016cites this paper
• Role of Redox Status in Development of Glioblastoma

  2016cites this paper
• Tumor cells have decreased ability to metabolize H2O2: Implications for pharmacological ascorbate in cancer therapy

  2016cites this paper
• Ascorbic acid and colon cancer: an oxidative stimulus to cell death depending on cell profile.

  2016cites this paper
• Transcriptomic and functional pathways analysis of ascorbate-induced cytotoxicity and resistance of Burkitt lymphoma

  2016cites this paper
• Fluorine-18-Labeled Thymidine Positron Emission Tomography (FLT-PET) as an Index of Cell Proliferation after Pharmacological Ascorbate-Based Therapy

  2016cites this paper
• High-dose vitamin C and cancer

  2016cites this paper
• Ascorbate Combination Therapy: New in the Toolbox?

  2016cites this paper
• The use of high‐dose intravenous vitamin C in the management of cancer: a case for vitamin C in the management of cancer

  2016cites this paper
• Natriuretic peptide receptor A inhibition suppresses gastric cancer development through reactive oxygen species-mediated G2/M cell cycle arrest and cell death.

  2016cites this paper
• Effect of Glucose on GLUT1-Dependent Intracellular Ascorbate Accumulation and Viability of Thyroid Cancer Cells

  2015cites this paper
• Treatment of Pancreatic Cancer with Pharmacological Ascorbate.

  2015cites this paper
• Roles of Autophagy Induced by Natural Compounds in Prostate Cancer

  2015cites this paper
• The unpaved journey of vitamin C in cancer treatment.

  2015cites this paper
• Pharmacological Ascorbate Radiosensitizes Pancreatic Cancer.

  2015cites this paper
• SIAH1-induced p34SEI-1 polyubiquitination/degradation mediates p53 preferential vitamin C cytotoxicity.

  2015cites this paper
• Radiosensitisation by pharmacological ascorbate in glioblastoma multiforme cells, human glial cells, and HUVECs depends on their antioxidant and DNA repair capabilities and is not cancer specific.

  2014cites this paper
• Cancer and Reduced Toxicity of Chemotherapy High-Dose Parenteral Ascorbate Enhanced Chemosensitivity of Ovarian

  2014cites this paper
• Pharmacological Doses of Daily Ascorbate Protect Tumors from Radiation Damage after a Single Dose of Radiation in an Intracranial Mouse Glioma Model

  2014cites this paper
• Interference of Skp2 effectively inhibits the development and metastasis of colon carcinoma.

  2014cites this paper
• Potential Therapeutics for Vitamin C and Cancer

  2014cites this paper
• Dosimetry for treating brain tumours in mice using a gamma irradiator

  2014cites this paper
• New Insights on Vitamin C and Cancer

  2014cites this paper
• Chlorambucil and ascorbic acid-mediated anticancer activity and hematological toxicity in Dalton's ascites lymphoma-bearing mice.

  2014cites this paper
• Ascorbate Combination Therapy: New Tool in the Anticancer Toolbox?

  2014cites this paper
• High-Dose Parenteral Ascorbate Enhanced Chemosensitivity of Ovarian Cancer and Reduced Toxicity of Chemotherapy

  2014cites this paper
• Extracellular iron diminishes anticancer effects of vitamin C: An in vitro study

  2014cites this paper
• Komplementärer Einsatz von Antioxidanzien und Mikronährstoffen in der Onkologie

  2013cites this paper
• The Stance of Antioxidants in Brain Tumors

  2013cites this paper
• Parenteral Ascorbate As a Cancer Therapeutic: A Reassessment Based on Pharmacokinetics

  2013cites this paper
• Pharmacological ascorbate and ionizing radiation (IR) increase labile iron in pancreatic cancer☆

  2013cites this paper
• Effect of ascorbic acid and X-irradiation on HL-60 human leukemia cells: the kinetics of reactive oxygen species.

  2013cites this paper
• Ascorbic acid: chemistry, biology and the treatment of cancer.

  2012cites this paper